Navigation Links
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
Date:3/11/2011

BOTHELL, Wash., March 11, 2011 /PRNewswire/ -- SCOLR Pharma, Inc. (OTC Bulletin Board: SCLR) today announced it has received a letter from the Food and Drug Administration (FDA) identifying deficiencies regarding its Abbreviated New Drug Application (ANDA) for extended-release pseudoephedrine.  

The Company said the letter identified a number of concerns that the FDA had with the conduct of the bioequivalence study submitted by SCOLR to support the application.  The deficiencies cited relate to the design and conduct of the study.  None of the issues raised relate to the product formulation.  Due to these deficiencies, the agency said it is unable to approve the ANDA application at this time.

Stephen J. Turner, SCOLR Pharma's President and CEO, said: "Although we are extremely disappointed with this situation, we are currently evaluating the deficiencies identified by the FDA to determine the most appropriate course of action.  We remain confident in our pseudoephedrine product and intend to rectify the FDA's concerns."

About SCOLR Pharma:Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including sta
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
2. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
3. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
4. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
5. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
6. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
7. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
8. SCOLR Pharma, Inc. Licenses Dietary Supplements
9. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
10. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
11. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 CVS Health (NYSE: CVS ) ... three leading regional health systems to enhance access to high-quality, ... include Baptist Health System in Alabama ; ... in Pennsylvania , Northwest Medical Center, including ... Tennova Healthcare in Tennessee ; and Premier ...
(Date:10/30/2014)... , Oct. 30, 2014  CytRx Corporation ... and development company specializing in oncology, today announced ... its lead drug candidate, aldoxorubicin.  The presentation, titled, ... Approach," will be given by Sant P. ... Oncology Center and principal investigator of the Company,s ...
(Date:10/30/2014)... Oct. 30, 2014 Today, DripDrop, the ... that it was awarded a two-year contract, effective ... company that serves the more than 100,000 members ... Association and Provista.  DripDrop also ... from member hospitals who attended the recent Novation ...
Breaking Medicine Technology:CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 2DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 3DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 4
... Reportlinker.com announces that a new market research ... Vaccines - Western Europe ... market research report package offers an in-depth perspective ... outlook for vaccines in Western European markets. The ...
... 2012 Reportlinker.com announces that a new ... catalogue: Pharmaceuticals: Global ... http://www.reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu Pharmaceuticals: Global Industry ... data and analysis covering the Pharmaceuticals industry. ...
Cached Medicine Technology:Vaccines - Western Europe 2Pharmaceuticals: Global Industry Guide 2Pharmaceuticals: Global Industry Guide 3Pharmaceuticals: Global Industry Guide 4Pharmaceuticals: Global Industry Guide 5Pharmaceuticals: Global Industry Guide 6Pharmaceuticals: Global Industry Guide 7Pharmaceuticals: Global Industry Guide 8Pharmaceuticals: Global Industry Guide 9Pharmaceuticals: Global Industry Guide 10Pharmaceuticals: Global Industry Guide 11Pharmaceuticals: Global Industry Guide 12Pharmaceuticals: Global Industry Guide 13Pharmaceuticals: Global Industry Guide 14Pharmaceuticals: Global Industry Guide 15
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... Norton HealthDay Reporter WEDNESDAY, ... plastics, chemical during pregnancy may have effects on genital development ... that baby boys born to moms with greater exposure to ... distance -- the space between the genitals and anus. Anogenital ... marker of exposure to androgens ("male" hormones) during pregnancy. ...
(Date:10/30/2014)... 2014 (HealthDay News) -- Many U.S. colleges have ... though tanning increases the risk for skin cancer, ... adults, particularly white women, so colleges should adopt ... researchers said. "Public health efforts are needed ... of the harms that indoor tanning poses to ...
(Date:10/30/2014)... Americans, opinions about the Affordable Care Act are sharply ... Democratic voters are strongly in favor of the Affordable ... of Democrats want the next Congress to move ahead ... the current law, while 44 percent want to expand ... one-third want the law repealed, and 27 percent want ...
(Date:10/30/2014)... the fact that a patient,s body is only ... a third of cancer patients experience psychosocial distress ... And, increasingly, care providers are exploring phone- and ... health challenges. A University of Colorado Cancer Center ... asks an important question: after decades of ...
Breaking Medicine News(10 mins):Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:Voters' Views on Obamacare Split Along Party Lines 2Health News:Decades of research: Effectiveness of phone counseling for cancer patients still unknown 2
... New medicines should be granted a provisional safety ... proven amongst the wider //population, experts have said ... ,Recent experience with Vioxx and some other ... after marketing, has shown that reliance on pre-marketing ...
... more he or she consumes sugary drinks, and extra calories, ... increase in TV viewing per day, we found higher intakes ... and total calories (46.3 more kcal/day)," said Sonia Miller, B.A., ... Harvard Medical School. ,Miller and her colleagues ...
... who smoke during pregnancy can cause permanent vascular damage ... and heart attack, according to a research. ... study showed that participants who were exposed to smoke ... damage that could be detected in young adulthood. ...
... of kidney tumors – cryoablation – is as effective ... was presented at the Society of Interventional Radiology’s 32nd ... shows that percutaneous cryoablation results in a slightly lower ... no major complications, and a 59.5 percent lower hospital ...
... pledged to eradicate the polio in the last four endemic ... long as needed till the last trace of the paralyzing ... hopefully final assault on polio, the United Nations health agency ... and then sustain for as long as needed, vaccination levels ...
... about half of all visits to psychotherapists, and most ... couples.// The therapist helps the couple work on eliminating ... conflict, explains the March 2007 issue of the Harvard ... little use of psychiatric diagnosis, but they do use ...
Cached Medicine News:Health News:Time to Overhaul Australia's Medicines Safety Surveillance System 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 3Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 2Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 3Health News:Freezing Kidney Tumors Effective and Less Expensive Than Laparoscopy 2Health News:UN Health Agency, Partners Seek Total Eradication of Polio 2
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... The InstaCheck® multi-drug test ... simply and easily. Negative results ... few as 3 minutes; positive ... A simple, one-time urine sample ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
AccuSign® DOA Series Opiates Test...
Medicine Products: